Robert N. Shapiro’s Edwards Lifesciences EW Stock Holding History

Robert N. Shapiro’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$95K	Buy	4,374 +696	+19%	+$14K	0.02%	362
2014 Q3	$63K	Buy	3,678 +1,518	+70%	+$24K	0.01%	442
2014 Q2	$31K	Hold	2,160	–	–	0.01%	536
2014 Q1	$27K	Hold	2,160	–	–	0.01%	546
2013 Q4	$24K	Hold	2,160	–	–	﹤0.01%	573
2013 Q3	$25K	Sell	2,160 -14,976	-87%	-$175K	﹤0.01%	749
2013 Q2	$191K	Buy	+17,136	New	+$203K	0.04%	263

Other funds holding EW

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Robert N. Shapiro's EW Position: Q4 2014 in Review

Robert N. Shapiro increased its Edwards Lifesciences (EW) stake by 19% in Q4 2014, buying an estimated $14K and bringing the position to 4,374 shares worth $95K. The position accounts for 0.02% of the portfolio, ranked #362.

Robert N. Shapiro first reported a position in EW in Q2 2013 and has held it in 7 quarters since. The position peaked at $191K in Q2 2013. 556 funds tracked by Wall St. Rank hold EW as of Q4 2014.

Robert N. Shapiro held 4,374 shares of Edwards Lifesciences worth $95K as of Q4 2014.
Robert N. Shapiro bought 696 Edwards Lifesciences shares in Q4 2014, an estimated $14K.
Edwards Lifesciences made up 0.02% of Robert N. Shapiro's portfolio in Q4 2014, its #362 holding.
Robert N. Shapiro first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 7 quarters since.
Robert N. Shapiro's Edwards Lifesciences position peaked at $191K in Q2 2013.
556 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2014.

Based on Robert N. Shapiro's 13F filing for Q4 2014, filed 19 Feb 2015.